Purchases and Sales Made in Q3 2024 in Aerovate Therapeutics, Inc. (AVTE)
This table provides information about the institutional ownership of Aerovate Therapeutics, Inc. (AVTE) during Q3 2024. The information is specifically focused on institutions that hold shares of Aerovate Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-92.5K- 83.85% |
$149K - $193K
|
17.8K
$47.7K
|
|
|
Nov 14, 2024
Q3 2024
|
Adar1 Capital Management, LLC
Austin, TX |
SELL
|
- |
-134K- 54.21% |
$216K - $280K
|
113K
$303K
|
|
|
Nov 14, 2024
Q3 2024
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-149K- 59.91% |
$240K - $312K
|
99.8K
$268K
|
|
|
Oct 03, 2024
Q3 2024
|
Sg Americas Securities, LLC
|
SELL
|
- |
-168K- 93.86% |
$271K - $352K
|
11K
$29.5K
|
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-445K- 69.37% |
$717K - $931K
|
197K
$527K
|